Transcription Activator-Like Nucleases Enable Allogeneic Chimeric Antigen Receptor-T Cell Therapy in Humans.

Flotte TR. Transcription Activator-Like Nucleases Enable Allogeneic Chimeric Antigen Receptor-T Cell Therapy in Humans. Hum Gene Ther. 2015 Nov; 26(11):iv.

View in: PubMed

subject areas

Antigens, CD
Antigens, Neoplasm
CD52 Antigen
Female
Genetic Engineering
Glycoproteins
Humans
Immunotherapy
Infant
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Receptors, Antigen, T-Cell
T-Lymphocytes

authors with profiles

Terence R Flotte MD